RESPIRAEASE Trademark

Trademark Overview

On Wednesday, September 17, 2025, a trademark application was filed for RESPIRAEASE with the United States Patent and Trademark Office. The USPTO has given the RESPIRAEASE trademark a serial number of 99399005. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, September 17, 2025. This trademark is owned by Shane Barnett. The RESPIRAEASE trademark is filed in the Medical Instrument Products category with the following description:

Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory conditions such as asthma, COPD, or other respiratory diseases.
respiraease

General Information

Serial Number99399005
Word MarkRESPIRAEASE
Filing DateWednesday, September 17, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, September 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"Respira"
Goods and ServicesNebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory conditions such as asthma, COPD, or other respiratory diseases.

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, September 17, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShane Barnett
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressFort Lauderdale, FL 33304

Trademark Events

Event DateEvent Description
Wednesday, September 17, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, September 17, 2025NEW APPLICATION ENTERED

Related Keywords

respiraease respiratory such conditions asthma copd diseases other treatment medication administering